Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,376 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study.
Bechlioulis A, Markozannes G, Chionidi I, Liberopoulos E, Naka KK, Ntzani EE, Liatis S, Rizzo M, Rizos EC. Bechlioulis A, et al. Among authors: rizzo m. J Diabetes Complications. 2023 Apr;37(4):108436. doi: 10.1016/j.jdiacomp.2023.108436. Epub 2023 Feb 23. J Diabetes Complications. 2023. PMID: 36842186 Clinical Trial.
Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials.
Patoulias D, Popovic DS, Stoian AP, Janez A, Sahebkar A, Rizzo M. Patoulias D, et al. Among authors: rizzo m. J Diabetes Complications. 2023 Aug;37(8):108529. doi: 10.1016/j.jdiacomp.2023.108529. Epub 2023 Jun 7. J Diabetes Complications. 2023. PMID: 37301063 Review.
2,376 results